학술논문

A phase 1b study of the allosteric extracellular FGFR2 inhibitor alofanib in patients with pretreated advanced gastric cancer
Document Type
Article
Source
In: Investigational New Drugs. (Investigational New Drugs, April 2023, 41(2):324-332)
Subject
Language
English
ISSN
15730646
01676997